Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors
View Patent ↗Pinane-substituted pyrimidinediamine derivatives and pharmaceutical compositions containing the derivatives are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the derivatives in treating diseases or conditions associated with Axl catalytic activity are also disclosed.
1. A compound of formula (Ia):
wherein:
n is 0 to 7;
m is 0 to 2;
R 1 , R 2 , R 4 and R 5 are each independently hydrogen, alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, —R 14 —OR 15 , —C(O)R 15 or —C(O)N(R 11 )R 12 ;
or R 4 and R 5 , together with the nitrogen to which they are attached, form an optionally substituted N-heteroaryl or an optionally substituted N-heterocyclyl;
R 3a , R 3b , R 3c , R 3d and R 3e are each independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, halo, haloalkyl, haloalkenyl, haloalkynyl, cyano, nitro, optionally substituted aryl, optionally substituted aralkyl, optionally substituted aralkenyl, optionally substituted aralkynyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted cycloalkylalkenyl, optionally substituted cycloalkylalkynyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heterocyclylalkenyl, optionally substituted heterocyclylalkynyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heteroarylalkenyl, optionally substituted heteroarylalkynyl, —R 17 —OR 16 , —R 17 —OC(O)—R 16 , —R 17 —N(R 16 ) 2 , —R 17 —C(O)R 16 , —R 17 —C(O)OR 16 , —R 17 —C(O)N(R 16 ) 2 , —R 17 —O—R 18 —C(O)N(R 16 ) 2 , —R 17 —O—R 18 —N(R 16 ) 2 , —R 17 —N(R 16 )C(O)OR 16 , —R 17 —N(R 16 )C(O)R 16 , —R 17 —N(R 16 )S(O) t R 16 (where t is 1 or 2), —R 17 —S(O) t OR 16 (where t is 1 or 2), —R 17 —S(O) p R 16 (where p is 0, 1 or 2), and —R 17 —S(O) t N(R 16 ) 2 (where t is 1 or 2), where each R 16 is independently hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl or optionally substituted heteroarylalkyl, each R 17 is independently a direct bond or a straight or branched alkylene or alkenylene chain, and R 18 is a straight or branched alkylene or alkenylene chain;
R 6 , R 7 and R 8 are each independently alkyl, haloalkyl, or —R 13 —OR 15 ;
each R 9 and R 10 is independently alkyl, halo, haloalkyl, aryl or aralkyl;
R 11 and R 12 are each independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, hydroxyalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted aralkenyl, optionally substituted aralkynyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted cycloalkylalkenyl, optionally substituted cycloalkylalkynyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heterocyclylalkenyl, optionally substituted heterocyclylalkynyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heteroarylalkenyl, optionally substituted heteroarylalkynyl, —R 14 —OR 15 , —R 14 —CN, —R 14 —NO 2 , —R 14 —N(R 15 ) 2 , —R 14 —C(O)OR 15 and —R 14 —C(O)N(R 15 ) 2 ;
optionally, R 11 and R 12 , together with the nitrogen to which they are attached, form an optionally substituted N-heteroaryl or an optionally substituted N-heterocyclyl;
R 13 is independently selected from the group consisting of a direct bond, an optionally substituted straight or branched alkylene chain, an optionally substituted straight or branched alkenylene chain and an optionally substituted straight or branched alkynylene chain;
each R 14 is independently selected from the group consisting of an optionally substituted straight or branched alkylene chain, an optionally substituted straight or branched alkenylene chain and an optionally substituted straight or branched alkynylene chain; and
each R 15 is independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted aralkenyl, optionally substituted aralkynyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted cycloalkylalkenyl, optionally substituted cycloalkylalkynyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heterocyclylalkenyl, optionally substituted heterocyclylalkynyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heteroarylalkenyl, and optionally substituted heteroarylalkynyl;
as an isolated stereoisomer or mixture thereof, or a pharmaceutically acceptable salt thereof.
2. The compound of claim 1 wherein:
n is 0 to 4;
m is 0 to 1;
R 1 , R 2 , R 4 and R 5 are each independently hydrogen, alkyl, cycloalkylalkyl, —R 14 —OR 15 , —C(O)R 15 or —C(O)N(R 11 )R 12 ;
R 3a , R 3b , R 3c , R 3d and R 3e are each independently selected from the group consisting of hydrogen, alkyl, halo, haloalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, —R 17 —OR 16 , —R 17 —N(R 16 ) 2 , —R 17 —C(O)R 16 , —R 17 —C(O)OR 16 , —R 17 —C(O)N(R 16 ) 2 , —R 17 —O—R 18 —C(O)N(R 16 ) 2 , —R 17 —O—R 18 —N(R 16 ) 2 , and —R 17 —S(O)N(R 16 ) 2 (where t is 1 or 2), where each R 16 is independently hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl or optionally substituted heteroarylalkyl, each R 17 is independently a direct bond or a straight or branched alkylene or alkenylene chain, and R 18 is a straight or branched alkylene or alkenylene chain;
R 6 , R 7 and R 8 are each independently alkyl, haloalkyl, or —R 13 —OR 15 ;
each R 9 and R 10 is independently alkyl, halo, haloalkyl, aryl or aralkyl;
R 11 and R 12 are each independently selected from the group consisting of hydrogen, alkyl, haloalkyl, hydroxyalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, —R 14 —OR 15 , —R 14 —CN, R 14 —NO 2 , —R 14 —N(R 15 ) 2 , —R 14 —C(O)OR 15 and —R 14 —C(O)N(R 15 ) 2 ;
R 13 is independently selected from the group consisting of a direct bond or an optionally substituted straight or branched alkylene chain;
each R 14 is an optionally substituted straight or branched alkylene chain; and
each R 15 is independently selected from the group consisting of hydrogen, alkyl, haloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, and optionally substituted heteroarylalkyl.
3. The compound of claim 2 wherein:
n is 0;
m is 0 to 1;
R 1 , R 2 , R 4 and R 5 are each independently hydrogen, alkyl, cycloalkylalkyl, or —R 14 —OR 15 ;
R 3a , R 3b , R 3c , R 3d and R 3e are each independently selected from the group consisting of hydrogen, alkyl, halo, haloalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, —R 17 —OR 16 , —R 17 —N(R 16 ) 2 , —R 17 —C(O)R 16 , —R 17 —C(O)OR 16 , —R 17 —C(O)N(R 16 ) 2 , —R 17 —O—R 18 —C(O)N(R 16 ) 2 , —R 17 —O—R 18 —N(R 16 ) 2 , and —R 17 —S(O) t N(R 16 ) 2 (where t is 1 or 2), where each R 16 is independently hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl or optionally substituted heteroarylalkyl, each R 17 is independently a direct bond or a straight or branched alkylene or alkenylene chain, and R 18 is a straight or branched alkylene or alkenylene chain;
R 6 , R 7 and R 8 are each independently alkyl, haloalkyl, or —R 13 —OR 15 ;
R 10 is alkyl, halo or haloalkyl;
R 13 is selected from the group consisting of a direct bond or an optionally substituted straight or branched alkylene chain;
R 14 is an optionally substituted straight or branched alkylene chain; and
R 15 is selected from the group consisting of hydrogen, alkyl, haloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, and optionally substituted heteroarylalkyl.
4. The compound of claim 3 wherein:
n is 0;
m is 0 to 1;
R 1 , R 2 , R 4 and R 5 are each independently hydrogen, alkyl, cycloalkylalkyl, or —R 14 —OR 15 ;
R 3a , R 3b , R 3c , R 3d and R 3e are each independently selected from the group consisting of hydrogen, alkyl, halo, haloalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, or optionally substituted heteroarylalkyl;
R 6 , R 7 and R 8 are each independently alkyl, haloalkyl, or —R 13 —OR 15 ;
R 10 is alkyl, halo or haloalkyl;
R 13 is selected from the group consisting of a direct bond or an optionally substituted straight or branched alkylene chain;
R 14 is an optionally substituted straight or branched alkylene chain; and
R 15 is selected from the group consisting of hydrogen, alkyl, haloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, and optionally substituted heteroarylalkyl.
5. The compound of claim 4 wherein:
n is 0;
m is 0 to 1;
R 1 , R 2 , R 4 and R 5 are each independently hydrogen, alkyl, cycloalkylalkyl, or —R 14 —OR 15 ;
R 3a , R 3b , and R 3e are each hydrogen;
R 3c and R 3d are each independently selected from the group consisting of hydrogen, alkyl, halo, haloalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, or optionally substituted heteroarylalkyl;
R 6 , R 7 and R 8 are each independently alkyl, haloalkyl, or —R 13 —OR 15 ;
R 10 is alkyl, halo or haloalkyl;
R 13 is selected from the group consisting of a direct bond or an optionally substituted straight or branched alkylene chain;
R 14 is an optionally substituted straight or branched alkylene chain; and
R 15 is selected from the group consisting of hydrogen, alkyl, haloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, and optionally substituted heteroarylalkyl.
6. The compound of claim 5 selected from the group consisting of:
(1R,2R,3S,5R)-2-(5-chloro-2-(4-morpholinophenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(3-fluoro-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(3-chloro-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(4-(pyridin-4-ylmethyl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(4-(4-(4-fluorophenyl)piperazin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(4-(1-methylpiperidin-4-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(2-(4-(4-acetylpiperazin-1-yl)phenylamino)-5-chloropyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(4-chloro-3-(4-ethylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(2-(3-(4-acetylpiperazin-1-yl)-4-chlorophenylamino)-5-chloropyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(2-(benzyloxy)ethyl)-2-(5-chloro-2-(3-fluoro-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)-6,6-dimethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(2-(3-(4-(methoxycarbonyl)piperazin-1-yl)-4-chlorophenylamino)-5-chloropyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(2-(3-fluoro-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)-2-(2-hydroxyethyl)-6,6-dimethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(2-(3-fluoro-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(3-fluoro-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(3-fluoro-4-(4-(diethylamino)piperidin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-fluoro-2-(3-chloro-4-(4,4-difluoropiperidin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-fluoro-2-(3-fluoro-4-(4,4-difluoropiperidin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-fluoro-2-(3-chloro-4-(4-methylsulfonylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-fluoro-2-(3-trifluoromethyl-4-(4-methylsulfonylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-fluoro-2-(3-chloro-4-(4-acetylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-fluoro-2-(3-trifluoromethyl-4-(4-acetylpiperazin-1yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(4-(4-(2-hydroxyethyl)piperazin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-methyl-2-(4-(4-(2-hydroxyethyl)piperazin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-methyl-2-(3-fluoro-4-(4-methylpiperazin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-methyl-2-(3-fluoro-4-(4,4-difluoropiperidin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-trifluoromethyl-2-(3-fluoro-4-(4-(diethylamino)piperidin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(3-fluoro-4-(4-(4-methylpiperidin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-fluoro-2-(3-fluoro-4-(4-(4-methylpiperidin-1-yl)piperidin-1-yl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide; and
(1R,2R,3S,5R)-2-(5-chloro-2-(3-fluoro-4-(4-(diethylamino)piperidin-1-yl)phenylamino)pyrimidin-4-ylamino)-N-cyclopropyl-2,6,6-trimethylbicyclo[3.1.1]heptane-3-carboxamide.
7. The compound of claim 3 wherein:
n is 0;
m is 0 to 1;
R 1 , R 2 , R 4 and R 5 are each independently hydrogen, alkyl, cycloalkylalkyl, or —R 14 —OR 15 ;
R 3a , R 3b , R 3c , R 3d and R 3e are each independently selected from the group consisting of hydrogen, alkyl, halo, haloalkyl, —R 17 —OR 16 , —R 17 —N(R 16 ) 2 , —R 17 —C(O)R 16 , —R 17 —C(O)OR 16 , —R 17 —C(O)N(R 16 ) 2 , —R 17 —O—R 18 —C(O)N(R 16 ) 2 , —R 17 —O—R 18 —N(R 16 ) 2 , and —R 17 —S(O) t N(R 16 ) 2 (where t is 1 or 2), where each R 16 is independently hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl or optionally substituted heteroarylalkyl, each R 17 is independently a direct bond or a straight or branched alkylene or alkenylene chain, and R 18 is a straight or branched alkylene or alkenylene chain;
R 6 , R 7 and R 8 are each independently alkyl, haloalkyl, or —R 13 —OR 15 ;
R 10 is alkyl, halo or haloalkyl;
R 13 is selected from the group consisting of a direct bond or an optionally substituted straight or branched alkylene chain;
R 14 is an optionally substituted straight or branched alkylene chain; and
R 15 is selected from the group consisting of hydrogen, alkyl, haloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, and optionally substituted heteroarylalkyl.
8. The compound of claim 7 wherein:
n is 0;
m is 0 to 1;
R 1 , R 2 , R 4 and R 5 are each independently hydrogen, alkyl, cycloalkylalkyl, or —R 14 —OR 15 ;
R 3a , R 3b and R 3e are each hydrogen;
R 3e and R 3d are each independently selected from the group consisting of hydrogen, alkyl, halo, haloalkyl, —R 17 —OR 16 , —R 17 —N(R 16 ) 2 , —R 17 —C(O)R 16 , —R 17 —C(O)OR 16 , —R 17 —C(ONR 16 ) 2 , —R 17 —O—R 18 —C(O)N(R 16 ) 2 , —R 17 —O—R 18 —N(R 16 ) 2 , and —R 17 —S(O) t N(R 16 ) 2 (where t is 1 or 2), where each R 16 is independently hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl or optionally substituted heteroarylalkyl, each R 17 is independently a direct bond or a straight or branched alkylene or alkenylene chain, and R 18 is a straight or branched alkylene or alkenylene chain;
R 6 , R 7 and R 8 are each independently alkyl, haloalkyl, or —R 13 —OR 15 ;
R 10 is alkyl, halo or haloalkyl;
R 13 is selected from the group consisting of a direct bond or an optionally substituted straight or branched alkylene chain;
R 14 is an optionally substituted straight or branched alkylene chain; and
R 15 is selected from the group consisting of hydrogen, alkyl, haloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl, and optionally substituted heteroarylalkyl.
9. The compound of claim 8 selected from the group consisting of:
(1R,2R,3S,5R)-2-(5-chloro-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(3-fluoro-4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(3-sulfamoylphenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(4-(2-methyl-2-(pyrrolidin-1-yl)propoxy)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(4-(2-(cyclopentylamino)ethoxy)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(4-(4-cyclohexylpiperazine-1-carbonyl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(4-(4-methylpiperazine-1-carbonyl)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-ylamino)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(3-fluoro-4-(2-(pyrrolidin-1-ypethoxy)phenylamino)pyrimidin-4-ylamino)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(4-(2-((cyclopentyl)(methyl)amino)ethoxy)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-fluoro-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-ylamino)-N,2,6,6-tetramethylbicyclo[3.1.1]heptane-3-carboxamide;
(1R,2R,3S,5R)-2-(5-chloro-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-ylamino)-N-cyclopropyl-2,6,6-trimethylbicyclo[3.1.1]heptane-3-carboxamide; and
(1R,2R,3S,5R)-2-(5-chloro-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-ylamino)-N-(1-methylethyl)-2,6,6-trimethylbicyclo[3.1.1]heptane-3-carboxamide.
10. A pharmaceutical composition comprising a pharmaceutically acceptable excipient and a therapeutically effective amount of a compound of formula (Ia):
wherein:
n is 0 to 7;
m is 0 to 2;
R 1 , R 2 , R 4 and R 5 are each independently hydrogen, alkyl, aryl, aralkyl, cycloalkyl, cycloalkylalkyl, —R 14 —OR 15 , —C(O)R 15 or —C(O)N(R 11 )R 12 ;
or R 4 and R 5 , together with the nitrogen to which they are attached, form an optionally substituted N-heteroaryl or an optionally substituted N-heterocyclyl;
R 3a , R 3b , R 3c , R 3d and R 3e are each independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, halo, haloalkyl, haloalkenyl, haloalkynyl, cyano, nitro, optionally substituted aryl, optionally substituted aralkyl, optionally substituted aralkenyl, optionally substituted aralkynyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted cycloalkylalkenyl, optionally substituted cycloalkylalkynyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heterocyclylalkenyl, optionally substituted heterocyclylalkynyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heteroarylalkenyl, optionally substituted heteroarylalkynyl, —R 17 —OR 16 , —R 17 —OC(O)—R 16 , —R 17 —N(R 16 ) 2 , —R 17 —C(O)R 16 , —R 17 —C(O)OR 16 , —R 17 —C(O)N(R 16 ) 2 , —R 17 —O—R 18 —C(O)N(R 16 ) 2 , —R 17 —O—R 18 —N(R 16 ) 2 , —R 17 —N(R 16 )C(O)OR 16 , —R 17 —N(R 16 )C(O)R 16 , —R 17 —N(R 16 )S(O) t R 16 (where t is 1 or 2), —R 17 —S(O) t OR 16 (where t is 1 or 2), —R 17 —S(O) p R 16 (where p is 0, 1 or 2), and —R 17 —S(O) t N(R 16 ) 2 (where t is 1 or 2), where each R 16 is independently hydrogen, alkyl, haloalkyl, cycloalkyl, cycloalkylalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heteroaryl or optionally substituted heteroarylalkyl, each R 17 is independently a direct bond or a straight or branched alkylene or alkenylene chain, and R 18 is a straight or branched alkylene or alkenylene chain;
R 6 , R 7 and R 8 are each independently alkyl, haloalkyl, or —R 13 —OR 15 ;
each R 9 and R 10 is independently alkyl, halo, haloalkyl, aryl or aralkyl;
R 11 and R 12 are each independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, hydroxyalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted aralkenyl, optionally substituted aralkynyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted cycloalkylalkenyl, optionally substituted cycloalkylalkynyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heterocyclylalkenyl, optionally substituted heterocyclylalkynyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heteroarylalkenyl, optionally substituted heteroarylalkynyl, —R 14 —OR 15 , —R 14 —CN, —R 14 —NO 2 , —R 14 —N(R 15 ) 2 , —R 14 —C(O)OR 15 and —R 14 —C(O)N(R 15 ) 2 ;
optionally, R 11 and R 12 , together with the nitrogen to which they are attached, form an optionally substituted N-heteroaryl or an optionally substituted N-heterocyclyl;
R 13 is independently selected from the group consisting of a direct bond, an optionally substituted straight or branched alkylene chain, an optionally substituted straight or branched alkenylene chain and an optionally substituted straight or branched alkynylene chain;
each R 14 is independently selected from the group consisting of an optionally substituted straight or branched alkylene chain, an optionally substituted straight or branched alkenylene chain and an optionally substituted straight or branched alkynylene chain; and
each R 15 is independently selected from the group consisting of hydrogen, alkyl, alkenyl, alkynyl, haloalkyl, haloalkenyl, haloalkynyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted aralkenyl, optionally substituted aralkynyl, optionally substituted cycloalkyl, optionally substituted cycloalkylalkyl, optionally substituted cycloalkylalkenyl, optionally substituted cycloalkylalkynyl, optionally substituted heterocyclyl, optionally substituted heterocyclylalkyl, optionally substituted heterocyclylalkenyl, optionally substituted heterocyclylalkynyl, optionally substituted heteroaryl, optionally substituted heteroarylalkyl, optionally substituted heteroarylalkenyl, and optionally substituted heteroarylalkynyl;
as an isolated stereoisomer or mixture thereof, or a pharmaceutically acceptable salt thereof.